Autoinjectors Market Expected to Achieve 21.8% CAGR by 2029: Growth Forecast Insights

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Autoinjectors Market Size By 2025?
The market for autoinjectors has experienced significant expansion in the past few years. Its size is expected to increase from $3.7 billion in 2024 to $4.51 billion in 2025, with a compound annual growth rate (CAGR) of 22.0%. This growth during the historic period is due to factors such as the rising occurrences of chronic illnesses, an increasing elderly population, the surge in the biotechnology and pharmaceutical industry, a growing preference among patients for self-administration and supportive regulatory measures.

How Big Is the Autoinjectors Market Size Expected to Grow by 2029?
Anticipated to experience an upsurge in the coming years, the autoinjectors market is projected to attain a valuation of $9.93 billion by 2029, growing at a compound annual growth rate (CAGR) of 21.8%. The surge within the prediction period is largely due to the broadening of therapeutic applications, escalating healthcare expenses, heightened emphasis on patient-oriented care, the rise of telemedicine and remote patient monitoring, and emergent markets. Notable trends expected during the projection period are customised drug delivery, interactive and smart autoinjectors, needleless autoinjectors, biologic drug delivery, and safety and security features.

View the full report here:
https://www.thebusinessresearchcompany.com/report/autoinjectors-global-market-report

Which Key Market Drivers Powering Autoinjectors Market Expansion and Growth?
The rise in chronic diseases is predicted to drive the autoinjectors market's expansion in the forthcoming years. Chronic diseases, defined as conditions persisting a year or more requiring ongoing medical care, contribute significantly to global mortality and disability. These include heart disease, cancer, rheumatoid arthritis, and diabetes. Autoinjectors are designed for repeated injections of biologics and hormones in patients requiring consistent dosages for managing long-lasting health conditions like diabetes and rheumatoid arthritis. To illustrate, research from the American Cancer Society, a US healthcare organization, projected in January 2022 that the US will see approximately 609,360 cancer deaths and 1.9 million novel cancer cases in 2022, equating to nearly 1,670 fatalities daily. The escalating occurrence of chronic diseases propels the growth of the autoinjectors market, as these mechanisms offer a practical and efficient solution for patients who need regular medication.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5249&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Autoinjectors Market?
The rise of technological innovations is forging the path of the autoinjectors market. Key enterprises in the autoinjectors industry are concentrating on creating technical solutions for autoinjectors to satisfy the need for a biologics delivery mechanism suitable for highly viscous substances. For example, Boehringer Ingelheim, a pharmaceutical company based in Germany, revealed in May 2023, the endorsement from the U.S. Food and Drug Administration (FDA) for its Cyltezo Pen, an autoinjector variant for Cyltezo (adalimumab-adbm), which is approved as a treatment for various chronic inflammatory diseases. The Cyltezo Pen, which is pre-filled with 40 mg/0.8 mL, will be made available in packs consisting of two, four, and six units.

What Are the Emerging Segments in the Autoinjectors Market?
The autoinjectors market covered in this report is segmented -

1) By Type: Disposable Autoinjectors, Reusable Autoinjectors
2) By Therapy: Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Anaphylaxis, Other Therapies
3) By Route Of Administration: Subcutaneous, Intramuscular
4) By Distribution Channel: Online Retailer, Pharmacy
5) By End User: Home Care Settings, Hospitals And Clinics, Other End-Users

Subsegments:
1) By Disposable Autoinjectors: Single-Use Disposable Autoinjectors, Pre-filled Disposable Autoinjectors
2) By Reusable Autoinjectors: Multi-Use Reusable Autoinjectors, Rechargeable Reusable Autoinjectors

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=5249&type=smp

Who Are the Global Leaders in the Autoinjectors Market?
Major companies operating in the autoinjectors market include AbbVie Inc., Mylan N.V., Eli Lilly and Company, Amgen Inc., Becton, Dickinson and Company, Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., Pfizer Inc., Bayer AG, Biogen Inc., AstraZeneca PLC, Haselmeier GmbH, Owen Mumford Ltd., Gerresheimer AG, Philip Morris International Inc., Oval Medical Technologies Ltd., Solteam Incorporation Co. Ltd., Elcam Medical Group (E3D) Ltd., Jabil Inc., Catalent Inc., SHL Medical AG, West Pharmaceutical Services Inc., Nemera Development S.A., Bespak Europe Ltd., AptarGroup Inc., Consort Medical plc, Terumo Corporation, Nipro Corporation, Medtronic plc, Integra LifeSciences Corporation, OssDsign AB, Xenco Medical LLC, Renishaw plc

Which are the Top Profitable Regional Markets for the Autoinjectors Industry?
North America was the largest region in the autoinjectors market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the autoinjectors market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5249

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.